Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Lien Van Eyck

Clinical Development Lead

Astrivax

Leuven, Belgium

2 profile visits

About me

My organisation

Astrivax

AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax is developing a first-in-class Plug & Play vaccine platform, for the development of prophylactic and therapeutic vaccines.

Additional questions

How would you categorise yourself?

ResearcherHealth care professional

Organisation Type

Biotech company/R&D

Areas of expertise

Data management, analytics and monitoringResearch and developmentVaccine R&DDiagnosticsClinical development and trialsOther

Therapeutic areas

Infectious diseases ImmunologyAutoimmune disorders Rare diseases

1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.

I agree